How can ConnectiveRx improve its patient support programs to increase medication adherence rates?

Introduction

To improve ConnectiveRx's patient support programs and increase medication adherence rates, we need to take a comprehensive look at the current user experience, identify pain points, and develop targeted solutions. I'll approach this challenge by analyzing key user segments, mapping the patient journey, and proposing data-driven improvements that align with both patient needs and business objectives.

Clarifying Questions

• Looking at ConnectiveRx's position in the healthcare ecosystem, I'm curious about the primary channels through which patients interact with our support programs. Could you elaborate on whether we're primarily digital, phone-based, or integrated with healthcare providers' systems?

Why it matters: This will help us understand where to focus our improvement efforts and which touchpoints have the most impact on adherence. Expected answer: A mix of digital and phone-based support, with some healthcare provider integration. Impact on approach: We'd focus on creating a seamless omnichannel experience if it's a mix, or prioritize digital optimization if that's the primary channel.

• Considering the critical nature of medication adherence, I'm wondering about our current performance metrics. What's our baseline adherence rate, and how does it compare to industry standards?

Why it matters: This helps us set realistic improvement targets and understand the scale of the challenge. Expected answer: Current adherence rate is around 60%, slightly below the industry average of 65%. Impact on approach: If we're significantly below average, we'd focus on quick wins; if we're close, we'd look for innovative solutions to push us ahead of the curve.

• Given the complexity of patient support programs, I'm interested in understanding our current data collection and analysis capabilities. How granular is our insight into patient behavior and adherence patterns?

Why it matters: This determines our ability to personalize interventions and measure the impact of our improvements. Expected answer: We have basic adherence data but limited insights into specific patient behaviors or reasons for non-adherence. Impact on approach: Limited data would push us towards solutions that also improve our data collection, while rich data would allow for more targeted interventions.